Meeting Schedule

 

The preliminary program is now available.

 
 
Monday 26 June

Monday
26 June

09:00 - 12:30

Short Course 1:
Primary Human Hepatocytes: Basic Aspects

12:30 - 13:45

Lunch

13:45 - 17:15

Concurrent Short Courses

Short Course 2:
New Human Hepatocyte Technologies

Short Course 3: Quantifying the in vivo Acticity of Human Drug Metabolizing Enzymes and Transporters

17:15 - 17:45

Refreshment Break

17:45 - 19:00

Meeting Opening and Keynote Lecture: Ribosomes as Targets for New Antibacterials

19:00 - 21:00

Welcome Reception

Tuesday


08:00 - 10:30

Concurrent Sessions
1 and 2

Session 1:
Indication-Specific Challenges for Drug Discovery and Development

Session 2:
Integrated Pharmacogenomics

10:30 - 11:00

Refreshment Break

11:00 - 13:30

Concurrent Sessions
3 and 4

Session 3:
Risk Assessment and Regulatory Expectations of Nucleotides in Drug Development 

Session 4:
Approaches to Quantify the in vitro Function of ABC Efflux Transporters

13:30 - 15:00

Lunch and Posters

15:00 - 17:30

Concurrent Sessions
5 and 6

Session 5:
Understanding Toxicity to Avoid Serious Adverse Drug Reactions in Early Clinical Trials

Session 6:
Recent Technology Advance-ments Relevant for DMPK

17:30 - 18:00

Refreshment Break

18:00 - 18:45

State-of-the-art Lecture: CYP2D6: A Para-digm for Understanding Genet. Variability in DMPK

Wednesday


08:00 - 09:00

Industry-Sponsored Sessions

09:00 - 10:00

State-of-the-art Lecture:
Undruggable Targets

10:00 - 10:30

Refreshment Break

10:30 - 13:00

Concurrent Sessions
7 and 8

Session 7:
New Investigator’s Forum: Skills Needed for DMPK Scientists

Session 8:
PBPK Beyond PK of Small Molecule Drugs

13:00 - 15:00

Lunch and Posters

15:00 - 17:15

Concurrent Sessions
9 and 10

Session 9: 
The Impact of Disease State on Xenobiotic Metabolism

Session 10: 
P(esticide) MPK and Human Health Risk Assessment

Thursday


08:00 - 10:30

Concurrent Sessions
11 and 12

Session 11:
Implementation of DDI Information for Individual Treatment

Session 12:
Non-standard Pathways in Drug Metabolism

10:30 - 11:00

Refreshment Break

11:00 - 12:00

State-of-the-art Lecture:
The Promise of Cancer Epigenetics

12:00 - 12:15

Poster Awards Presentation

12:15 - 13:15

Lunch and Posters

13:15 - 15:45

Session 13:
Understanding and Targeting the Human Microbiome

15:45 - 16:15

Closing Ceremony